PL1787649T3 - Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją - Google Patents

Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją

Info

Publication number: PL1787649T3
Authority: PL; Poland
Prior art keywords: estradiolvalerate; dienogest; oral treatment; uterine bleeding; dysfunctional uterine
Prior art date: 2005-10-13

Application number

PL05022324T

Other languages

English (en)

Inventor

Susan Zeun

Pol Boudes

Jan Endrikat

Angelo Secci

Holger Zimmermann

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-13

Filing date

2005-10-13

Publication date

2009-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1787649(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-10-13 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2009-08-31 Publication of PL1787649T3 publication Critical patent/PL1787649T3/pl

Links

206010013908 Dysfunctional uterine bleeding Diseases 0.000 title 1
RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 title 1
206010027514 Metrorrhagia Diseases 0.000 title 1
239000003433 contraceptive agent Substances 0.000 title 1
230000002254 contraceptive effect Effects 0.000 title 1
AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 title 1
229960003309 dienogest Drugs 0.000 title 1
229960004766 estradiol valerate Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

PL05022324T 2005-10-13 2005-10-13 Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją PL1787649T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05022324A EP1787649B1 (de)	2005-10-13	2005-10-13	Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption

Publications (1)

Publication Number	Publication Date
PL1787649T3 true PL1787649T3 (pl)	2009-08-31

Family

ID=35811580

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL05022324T PL1787649T3 (pl)	2005-10-13	2005-10-13	Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją
PL06806225T PL1933843T3 (pl)	2005-10-13	2006-10-12	Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL06806225T PL1933843T3 (pl)	2005-10-13	2006-10-12	Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji

Country Status (22)

Country	Link
EP (2)	EP1787649B1 (pl)
JP (2)	JP5735200B2 (pl)
KR (2)	KR101218872B1 (pl)
CN (1)	CN101312733A (pl)
AR (1)	AR056694A1 (pl)
AT (2)	ATE424828T1 (pl)
CA (1)	CA2623024C (pl)
CL (1)	CL2011000283A1 (pl)
CY (2)	CY1110321T1 (pl)
DE (2)	DE502005006837D1 (pl)
DK (2)	DK1787649T3 (pl)
DO (1)	DOP2006000221A (pl)
ES (2)	ES2322479T3 (pl)
HR (1)	HRP20090256T1 (pl)
ME (1)	ME01056B (pl)
PE (2)	PE20100090A1 (pl)
PL (2)	PL1787649T3 (pl)
PT (2)	PT1787649E (pl)
SI (2)	SI1787649T1 (pl)
TW (2)	TWI328453B (pl)
UY (1)	UY29861A1 (pl)
WO (1)	WO2007042296A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DK1787649T3 (da) *	2005-10-13	2009-06-02	Bayer Schering Pharma Ag	Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4429374C1 (de) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
ATE249222T1 (de) *	1996-07-26	2003-09-15	Wyeth Corp	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6251956B1 (en)	1998-08-20	2001-06-26	Ortho Pharmaceutical Corporation	Combination progestin oral contraceptive regimen
EP1462106A1 (en) *	2003-03-28	2004-09-29	Pantarhei Bioscience B.V.	Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) *	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DK1787649T3 (da) *	2005-10-13	2009-06-02	Bayer Schering Pharma Ag	Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception

2005
- 2005-10-13 DK DK05022324T patent/DK1787649T3/da active
- 2005-10-13 AT AT05022324T patent/ATE424828T1/de active
- 2005-10-13 SI SI200530672T patent/SI1787649T1/sl unknown
- 2005-10-13 EP EP05022324A patent/EP1787649B1/de not_active Revoked
- 2005-10-13 DE DE502005006837T patent/DE502005006837D1/de not_active Expired - Lifetime
- 2005-10-13 ES ES05022324T patent/ES2322479T3/es not_active Expired - Lifetime
- 2005-10-13 PT PT05022324T patent/PT1787649E/pt unknown
- 2005-10-13 ME MEP-2009-171A patent/ME01056B/me unknown
- 2005-10-13 PL PL05022324T patent/PL1787649T3/pl unknown
2006
- 2006-10-12 CN CNA2006800381810A patent/CN101312733A/zh active Pending
- 2006-10-12 ES ES06806225T patent/ES2360302T3/es active Active
- 2006-10-12 KR KR1020107014574A patent/KR101218872B1/ko active Active
- 2006-10-12 CA CA2623024A patent/CA2623024C/en active Active
- 2006-10-12 PE PE2009001256A patent/PE20100090A1/es not_active Application Discontinuation
- 2006-10-12 JP JP2008534936A patent/JP5735200B2/ja active Active
- 2006-10-12 WO PCT/EP2006/009867 patent/WO2007042296A1/de not_active Ceased
- 2006-10-12 PL PL06806225T patent/PL1933843T3/pl unknown
- 2006-10-12 PT PT06806225T patent/PT1933843E/pt unknown
- 2006-10-12 KR KR1020087011203A patent/KR20080065651A/ko not_active Ceased
- 2006-10-12 DE DE502006008853T patent/DE502006008853D1/de active Active
- 2006-10-12 DK DK06806225.6T patent/DK1933843T3/da active
- 2006-10-12 PE PE2006001241A patent/PE20070555A1/es not_active Application Discontinuation
- 2006-10-12 AT AT06806225T patent/ATE497387T1/de active
- 2006-10-12 EP EP06806225A patent/EP1933843B1/de active Active
- 2006-10-12 TW TW095137564A patent/TWI328453B/zh active
- 2006-10-12 SI SI200630991T patent/SI1933843T1/sl unknown
- 2006-10-13 AR ARP060104489A patent/AR056694A1/es not_active Application Discontinuation
- 2006-10-13 DO DO2006000221A patent/DOP2006000221A/es unknown
- 2006-10-13 UY UY29861A patent/UY29861A1/es not_active Application Discontinuation
2007
- 2007-01-09 TW TW096100872A patent/TW200829255A/zh unknown
2009
- 2009-05-05 HR HR20090256T patent/HRP20090256T1/xx unknown
- 2009-06-11 CY CY20091100621T patent/CY1110321T1/el unknown
2011
- 2011-02-10 CL CL2011000283A patent/CL2011000283A1/es unknown
- 2011-05-02 CY CY20111100422T patent/CY1111406T1/el unknown
2012
- 2012-11-19 JP JP2012253067A patent/JP2013047269A/ja active Pending

Also Published As

Publication number	Publication date
TW200731977A (en)	2007-09-01
PT1933843E (pt)	2011-04-29
TW200829255A (en)	2008-07-16
CA2623024C (en)	2012-03-06
DK1787649T3 (da)	2009-06-02
EP1933843B1 (de)	2011-02-02
PE20070555A1 (es)	2007-07-12
JP5735200B2 (ja)	2015-06-17
CN101312733A (zh)	2008-11-26
TWI328453B (en)	2010-08-11
DE502005006837D1 (de)	2009-04-23
ATE497387T1 (de)	2011-02-15
WO2007042296A1 (de)	2007-04-19
ATE424828T1 (de)	2009-03-15
KR20100082389A (ko)	2010-07-16
JP2009511526A (ja)	2009-03-19
ME01056B (me)	2012-10-20
PL1933843T3 (pl)	2011-06-30
CA2623024A1 (en)	2007-04-19
JP2013047269A (ja)	2013-03-07
DK1933843T3 (da)	2011-04-18
CY1111406T1 (el)	2015-08-05
DE502006008853D1 (de)	2011-03-17
ES2322479T3 (es)	2009-06-22
UY29861A1 (es)	2007-05-31
EP1787649A1 (de)	2007-05-23
ES2360302T3 (es)	2011-06-02
SI1933843T1 (sl)	2011-06-30
PE20100090A1 (es)	2010-03-12
KR20080065651A (ko)	2008-07-14
HRP20090256T1 (en)	2009-06-30
PT1787649E (pt)	2009-05-08
CL2011000283A1 (es)	2011-07-08
EP1787649B1 (de)	2009-03-11
SI1787649T1 (sl)	2009-08-31
KR101218872B1 (ko)	2013-01-07
EP1933843A1 (de)	2008-06-25
DOP2006000221A (es)	2007-08-31
AR056694A1 (es)	2007-10-17
CY1110321T1 (el)	2015-01-14

Publication	Publication Date	Title
GB0713746D0 (en)	2007-08-22	Device for reshaping hard and soft tissues of the jaw and dentition
ZA200710387B (en)	2008-12-31	Method and composition for use in preparation of a patient for surgery
HUE038099T2 (hu)	2018-09-28	Kompozíciók és módszerek sebgyógyulás és szöveti regeneráció elõsegítésére
IL191526A0 (en)	2009-09-22	Intrauterine ultrasound and method for use
PT1729656E (pt)	2014-02-13	Tesouras cirúrgicas ultrassónicas e almofada de tecido para as mesmas
PL2148681T3 (pl)	2016-09-30	Selektywny modulator progesteronu w leczeniu krwawienia z macicy
IL185283A0 (en)	2008-02-09	Intrauterine fallopian tube occlusion device and method for use
PL1729656T3 (pl)	2014-03-31	Ultradźwiękowe nożyce chirurgiczne oraz nakładka ochronna tkanki do nich
EP1855598A4 (en)	2014-03-26	METHOD AND DEVICES FOR ANCHORING IN SOFT TISSUE
IL188922A0 (en)	2008-08-07	Benzoquinazoline derivatives and their use in treating bone disorders
IL182748A0 (en)	2007-09-20	USE OF AN mTOR INHIBITOR IN TREATMENT OF UTERINE LEIOMYOMA
SG10201701904TA (en)	2017-05-30	Management of breakthrough bleeding in extended hormonal contraceptive regimens
IL180899A0 (en)	2007-07-04	Pharmaceutical composition comprising drospirenone and ethynylestradiol
EP1998787A4 (en)	2010-04-21	RECOVERY AND REPAIR OF ORAL TISSUE
PT1787649E (pt)	2009-05-08	Utilização de valerato de estradiol em combinação com dienogest para a terapia oral da hemorragia uterina disfuncional em conjunto com uma contracepção oral
ZA200706016B (en)	2008-12-31	Compositions and methods for promoting wound healing and tissue regeneration
EP1736173A4 (en)	2009-12-16	MEANS FOR THE TREATMENT OF TISSUE DAMAGE AND THERAPEUTIC PROCEDURE
SG121919A1 (en)	2006-05-26	Device for cauterising tissue and uses thereof
EP1954800A4 (en)	2010-03-03	COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP2127681A4 (en)	2011-10-12	THERAPEUTIC AGENT AGAINST PARODONTAL DISEASES AND ALVEOLAR BONE LOSS THROUGH OPERATION
EP1928247A4 (en)	2009-10-28	COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
GB0717243D0 (en)	2007-10-17	Device for reshaping hard and soft tissues of the jaw and dentition
TH0601005011A (th)	2016-03-23	การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก
PL1764097T3 (pl)	2011-08-31	Sposoby i kompozycje kojące tkanki jamy ustnej i nosa
AU2005902493A0 (en)	2005-06-02	Method and composition for use in preparation of a patient for surgery